OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

Archive for mai, 2025

Special Communication on oncNGS PCP published in ESMO Open

Special Communication on oncNGS PCP published in ESMO Open

Improving the Cancer Care with Innovative ctDNA Analysis The OncNGS consortium is excited to announce the publication of its manuscript, detailing the development of new[…]
Read More

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer